The Archives of Bone and Joint Surgery

The Archives of Bone and Joint Surgery

Arthropathy in People with Mild Hemophilia

Document Type : In Brief

Author
Department of Orthopaedic Surgery, La Paz University Hospital, Madrid, Spain
10.22038/abjs.2025.90665.4103
Abstract
In people with mild hemophilia (PwMH) it is essential to characterize the presence of articular complications to develop approaches to minimize the burden of the disease. To this end, on 5 August 2025 a literature search was conducted in PubMed using the keywords “arthropathy mild hemophilia.” Higher burden of arthropathy among PwMH compared to the general population has been reported. Arthropathy of the ankle in PwMH is frequent, is often disabling, and is due to episodes of bleeding into the ankle joint during childhood. It has been reported that 36.5% of PwMH have arthropathy. Patient age and factor levels are the most important risk factors associated with the development of arthropathy in PwMH. The risk of developing arthropathy increased by 7.9% for each additional year of the minimum factor VIII levels required to prevent total and spontaneous joint bleeds (19.2 IU/dL and 17.7 IU/dL, respectively) age and decreased by 7.7% for each 1 IU/dL increase in clotting factor. The minimum FVIII levels required to prevent total and spontaneous joint bleeds in PwMH have been identified (19.2 IU/dL and 17.7 IU/dL, respectively). The need for more careful monitoring of PwMH is required.
Level of evidence: III
Keywords
Subjects

Benson G, Auerswald G, Dolan G, et al.  Blood Transfus. 2018;16(6):535-544. doi: 10.2450/2017.0150-17.
2. De la Corte-Rodriguez H, Rodriguez-Merchan EC. The role of physical medicine and rehabilitation in haemophiliac patients. Blood Coagul Fibrinolysis. 2013;24(1):1-9. doi: 10.1097/MBC.0b013e32835a72f3.
3. Carulli C, Rizzo AR, Innocenti M.  Hip Arthropathy in haemophilia. J Clin Med. 2017;6(4):44. doi: 10.3390/jcm6040044.
4. Mortazavi SJ, Bagheri N, Farhoud A, Hadi Kalantar S, Ghadimi E. Total knee arthroplasty in patients with hemophilia: what do we know? Arch Bone Jt Surg. 2020;8(4):470-478. doi: 10.22038/abjs.2019.42247.2149.
5. Rodriguez-Merchan EC. The current role of ankle arthrodesis in hemophilic patients. Arch Bone Jt Surg. 2022;10(2):129-134. doi: 10.22038/abjs.2020.47865.2366.
6. Chiari JB, Prozora S, Feinn R, Louizos E, Gallagher PG, Bona R. Joint bleeds in mild hemophilia: prevalence and clinical characteristics. Haemophilia. 2024;30(2):331-335. doi: 10.1111/hae.14939.
7. Daffunchio C, Landro ME, Galatro G, et al. How mild is mild haemophilia? Haemophilia. 2023;29(2):530-537. doi: 10.1111/hae.14750.
8. Osooli M, Lövdahl S, Steen Carlsson K, et al. Comparative burden of arthropathy in mild haemophilia: a register-based study in Sweden. Haemophilia. 2017;23(2):e79-e86. doi: 10.1111/hae.13166.
9. Gilchrist GS, Hagedorn AB, Stauffer RN. Severe degenerative joint disease. Mild and moderately  severe hemophilia A. JAMA. 1977;238(22):2383-2385. PMID: 578865.
10. Streit A, Furlan M, Beck EA. [Desamino-8-D-arginine vasopressin nose drops in the treatment of mild hemophilia A and von Willebrand's disease]. Schweiz Med Wochenschr. 1984;114(40):1389-1391. PMID: 6333722.
11. Bovill EG, Burns SL, Golden EA. Factor VIII antibody in a patient with mild haemophilia. Br J Haematol. 1985;61(2):323-328. doi: 10.1111/j.1365-2141.1985.tb02832.x.
12. Bairey O, Shaklai M, Inbal A. Haemarthrosis in patients with mild coagulation factor deficiency. Blood Coagul Fibrinolysis. 1991;2(5):669-671. doi: 10.1097/00001721-199110000-00014.
13. Aydogdu S, Memis A, Kavakli K, Balkan C. The pelvi-femoral incomplete bone bridge in a patient with mild haemophilia. Haemophilia. 2001;7(2):224-226. doi: 10.1046/j.1365-2516.2001.00496.x.
14. Bauduer F, Ducout L, Bendriss P, Falaises B, Lavergne JM. Mild haemophilia A discovered in a previously multi-operated 73-year-old man: characterization of a new mutation. Haemophilia. 2001;7(4):419-421. doi: 10.1111/j.1365-2516.2001.00512.x.
15. Ling M, Heysen JP, Duncan EM, Rodgers SE, Lloyd JV. High incidence of ankle arthropathy in mild and moderate haemophilia A. Thromb Haemost. 2011;105(2):261-268. doi: 10.1160/TH10-07-0492.
16. De la Corte-Rodriguez H, Rodriguez-Merchan EC, Alvarez-Roman MT, Martin-Salces M, Rivas-Pollmar I, Jimenez-Yuste V. Arthropathy in people with mild haemophilia: exploring risk factors. Thromb Res. 2022;211:19-26. doi: 10.1016/j.thromres.2022.01.010.
17. Zwagemaker AF, Kloosterman FR, Hemke R, et al. Joint status of patients with nonsevere hemophilia A. J Thromb Haemost. 2022;20(5):1126-1137. doi: 10.1111/jth.15676.
18. Kloosterman FR, Zwagemaker AF, Bagot CN, et al. The bleeding phenotype in people with nonsevere hemophilia. Blood Adv. 2022;6(14):4256-4265. doi: 10.1182/bloodadvances.2022007620.
19. Agosti P, Siboni SM, Scardo S, Torri A, Gualtierotti R, Peyvandi F. Minimum factor VIII levels to prevent joint bleeding in mild hemophilia A. Blood Adv. 2023;7(23):7209-7215. doi: 10.1182/bloodadvances.2023011366.
20. Rodeghiero F, Ghiotto L, Pontalto L, et al. Mild or moderate hemophilia is not always a mild or moderate bleeding disorder: Back to the clinical phenotype. Hemasphere. 2025;9(3):e70111. doi: 10.1002/hem3.70111.
 
 
 
 
Volume 14, Issue 11
November 2026
Pages 748-753

  • Receive Date 28 August 2025
  • Accept Date 23 December 2025